Canada markets closed

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
154.54-6.16 (-3.83%)
At close: 04:00PM EST
153.82 -0.72 (-0.47%)
After hours: 06:49PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close160.70
Open161.93
Bid153.05 x 900
Ask160.00 x 800
Day's Range152.88 - 164.35
52 Week Range90.29 - 464.00
Volume2,473,667
Avg. Volume3,514,932
Market Cap37.479B
Beta (5Y Monthly)-1.38
PE Ratio (TTM)4.90
EPS (TTM)31.55
Earnings DateMar. 30, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est307.14
  • Zacks

    Pfizer (PFE), BioNTech Begin Omicron-Based COVID-19 Jab Study

    Pfizer (PFE) and BioNTech (BNTX) announce that the first participants in a clinical study on its Omicron-specific COVID-19 vaccine candidate have been dosed.

  • Zacks

    Moderna (MRNA) Starts Study for Omicron-Specific Booster Jab

    Moderna (MRNA) doses the first participant in a phase II study on its Omicron specific COVID-19 booster candidate in a mid-stage study.

  • Motley Fool

    Why Coronavirus Vaccine Stocks Topped the Market Today

    Shares of coronavirus vaccine makers generally had a good Wednesday on the back of a coming push on additional jabs, plus a notable recommendation boost by a prominent investment bank. In contrast to the day's dip in the S&P 500 index, Moderna (NASDAQ: MRNA) stock enjoyed a 1.6% lift, Comirnaty vaccine co-developers Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) respectively rose by 0.9% and 2.7%, and perennial underdog Novavax (NASDAQ: NVAX) gained 2.6%.